The effect of probenecid and MK-571 on the feto-maternal transfer of saquinavir in dually perfused human term placenta

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 5, 2009, Pages 588-592

  Rahi, Mea Melissa ^a   Heikkinen, Tuija Maarit ^a   Hakala, Kristo Eerik ^a   Laine, Kari Petri ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

MK 571; MRP1; OATP2B1; Placenta; Probenecid; Saquinavir

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; ORGANIC ANION TRANSPORTER 2; PHENAZONE; PROBENECID; SAQUINAVIR; VERLUKAST;

AREA UNDER THE CURVE; ARTICLE; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG POTENTIATION; FEMALE; FETUS; HUMAN; HUMAN TISSUE; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNCYTIOTROPHOBLAST;

ANTIPYRINE; BIOLOGICAL TRANSPORT; FEMALE; HIV PROTEASE INHIBITORS; HUMANS; MATERNAL-FETAL EXCHANGE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; PERFUSION; PLACENTA; PREGNANCY; PROBENECID; PROPIONATES; QUINOLINES; SAQUINAVIR; TROPHOBLASTS;

EID: 67349258554     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.05.005     Document Type: Article

References (39)

1. Ala-Kokko T.I., Myllynen P., and Vähäkangas K. Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology. Int. J. Obstet. Anesth. 9 (2000) 26-38
2. Bakos E., and Homolya L. Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch. 453 (2007) 621-641
3. Berger V., Gabriel A.F., Sergent T., Trouet A., Larondelle Y., and Schneider Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol. Lett. 140-141 (2003) 465-476
4. Forestier F., de Renty P., Peytavin G., Dohin E., Farinotti R., and Mandelbrot L. Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. Am. J. Obstet. Gynecol. 185 (2001) 178-181
5. Fromm M.F. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 25 (2004) 423-429
6. Garcia P.M., Kalish L.A., Pitt J., Minkoff H., Quinn T.C., Burchett S.K., Kornegay J., Jackson B., Moye J., Hanson C., Zorrilla C., and Lew J.F. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N. Engl. J. Med. 341 (1999) 394-402
7. Gedeon C., Behravan J., Koren G., and Piquette-Miller M. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta 27 (2006) 1096-1102
8. Grube M., Köck K., Karner S., Reuther S., Ritter C.A., Jedlitschky G., and Kroemer H.K. Modification of OATP2B1-mediated transport by steroid hormones. Mol. Pharmacol. 70 (2006) 1735-1741
9. Haimeur A., Conseil G., Deeley R.G., and Cole S.P.C. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug Metab. 5 (2004) 21-53
10. Heikkinen T., Ekblad U., and Laine K. Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta. Psychopharmacology 153 (2001) 450-454
11. Heikkinen T., Ekblad U., and Laine K. Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. BJOG 109 (2002) 1003-1008
12. Janneh O., Jones E., Chandler B., Owen A., and Khoo S.H. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. J. Antimicrob. Chemother. 60 (2007) 987-993
13. Kullak-Ublick G.A., Ismair M.G., Stieger B., Landmann L., Huber R., Pizzagalli F., Fattinger K., Meier P.J., and Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120 (2001) 525-533
14. Letschert K., Faulstich H., Keller D., and Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol. Sci. 91 (2006) 140-149
15. Mathias A.A., Hitti J., and Unadkat J.D. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) 963-969
16. Mikkaichi T., Suzuki T., Tanemoto M., Ito S., and Abe T. The organic anion transporter (OATP) family. Drug Metab. Pharmacokin. 19 (2004) 171-179
17. Mougey E.B., Feng H., Castro M., Irvin C.G., and Lima J.J. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet. Genomics 19 (2009) 129-138
18. Munoz M., Henderson M., Haber M., and Norris M. Role of the MRP1/ABCC1 multidrug transporter protein in cancer. IUBMB Life 59 (2007) 752-757
19. Myllynen P., Pasanen M., and Vähäkangas K. The fate and effects of xenobiotics in human placenta. Expert Opin. Drug Metab. Toxicol. 3 (2007) 331-346
20. Mölsä M., Heikkinen T., Hakkola J., Hakala K., Wallerman O., Wadelius M., Wadelius C., and Laine K. Functional role of P-glycoprotein in the human blood-placenta barrier. Clin. Pharmacol. Ther. 78 (2005) 123-131
21. Nagashige M., Ushigome F., Koyabu N., Hirata K., Kawabuchi M., Hirakawa T., Satoh S., Tsukimori K., Nakano H., Uchiumi T., Kuwano M., Ohtani H., and Sawada Y. Basal membrane localization of MRP1 in human placental trophoblast. Placenta 24 (2003) 951-958
22. Parry S., and Zhang J. Multidrug resistance proteins affect drug transmission across the placenta. Am. J. Obstet. Gynecol. 196 (2007) 476.e1-476.e6
23. Pávek P., Fendrich Z., Staud F., Malákova J., Brozmanová H., Láznícek M., Semecký V., Grundmann M., and Palicka V. Influence of P-glycoprotein on the transplacental passage of cyclosporine. J. Pharm. Sci. 90 (2001) 1583-1592
24. Renes J., de Vries E.E., Hooiveld G.J., Krikken I., Jansen P.L., and Müller M. Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem. J. 350 (2000) 555-561
25. Ripamonti D., Cattaneo D., Maggiolo F., Airoldi M., Frigerio L., Bertuletti P., Ruggeri M., and Suter F. Atazanavir plus low-dose ritonavir in preganacy: pharmacokinetics and placental transfer. AIDS 21 (2007) 2409-2415
26. Sata R., Ohtani H., Tsujimoto M., Murakami H., Koyabu N., Nakamura T., Uchiumi T., Kuwano M., Nagata H., Tsukimori K., Nakano H., and Sawada Y. Functional analysis of organic cation transporter 3 expressed in human placenta. J. Pharmacol. Exp. Ther. 315 (2005) 888-895
27. Schneider H., Panigel M., and Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am. J. Obstet. Gynecol. 114 (1972) 822-828
28. Smit J.W., Huisman M.T., van Tellingen O., Wiltshire H.R., and Schinkel A.H. Absence of pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104 (1999) 1441-1447
29. St-Pierre M.V., Hagenbuch B., Ugele B., Meier P.J., and Stallmach T. Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta. J. Clin. Endocrinol. Metab. 87 (2002) 1856-1863
30. St-Pierre M.V., Serrano M.A., Macias R.I., Dubs U., Hoechli M., Lauper U., Meier P.J., and Marin J.J. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R1495-1503
31. Su Y., Zhang X., and Sinko P.J. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells. Mol. Pharm. 1 (2004) 49-56
32. Sudhakaran S., Ghabrial H., Nation R.L., Kong D.C., Gude N.M., Angus P.W., and Rayner C.R. Differential bidirectional transfer of indinavir in the isolated perfused human placenta. Antimicrob. Agents Chemother. 49 (2005) 1023-1028
33. Ugele B., Bahn A., and Rex-Haffner M. Functional differences in steroid sulfate uptake of organic anioin transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta. J. Steroid. Biochem. Mol. Biol. 111 (2008) 1-6
34. Ugele B., St-Pierre M.V., Pihusch M., Bahn A., and Hantschmann P. Characterization and identification of steroid sulfate transporters of human placenta. Am. J. Physiol. Endocinol. Metab. 2 (2003) 390-398
35. Unadkat J.D., Dahlin A., and Vijay S. Placental drug transporters. Curr. Drug. Metab. 5 (2004) 125-131
36. van der Aa E.M., Peereboom-Stegeman J.H., Noordhoek J., Gribnau F.W., and Russel F.G. Mechanisms of drug transfer across the human placenta. Pharm. World Sci. 20 (1998) 139-148
37. Wang Z., Sew P.H., Ambrose H., Ryan S., Chong S.S., Lee E.J., and Lee C.G. Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region. BMC Genomics 7 (2006) 111
38. Whitley A.C., Sweet D.H., and Walle T. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metab. Dispos. 33 (2005) 1097-1100
39. Williams G.C., Liu A., Knipp G., and Sinko P.J. Direct evidence that saquinavir is transporteted by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob. Agents Chemother. 46 (2002) 3456-3462